Shares of Aurora Cannabis Inc. (TSE:ACB - Get Free Report) shot up 41.3% on Wednesday . The stock traded as high as C$7.57 and last traded at C$7.46. 934,168 shares changed hands during trading, an increase of 184% from the average session volume of 329,183 shares. The stock had previously closed at C$5.28.
Analyst Ratings Changes
Several equities research analysts have commented on the company. ATB Capital lowered their price objective on Aurora Cannabis from C$11.00 to C$8.50 in a research report on Tuesday, December 17th. TD Securities upgraded Aurora Cannabis to a "strong-buy" rating in a research report on Thursday, December 12th. Finally, Atb Cap Markets raised shares of Aurora Cannabis from a "hold" rating to a "strong-buy" rating in a research note on Wednesday. Three equities research analysts have rated the stock with a hold rating, one has issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, Aurora Cannabis presently has an average rating of "Moderate Buy" and an average target price of C$5.85.
Read Our Latest Stock Report on ACB
Aurora Cannabis Price Performance
The stock has a 50 day moving average price of C$6.12 and a 200-day moving average price of C$7.18. The company has a debt-to-equity ratio of 16.95, a current ratio of 3.76 and a quick ratio of 2.48. The stock has a market capitalization of C$471.72 million, a price-to-earnings ratio of -13.70 and a beta of 2.71.
Aurora Cannabis (TSE:ACB - Get Free Report) last announced its earnings results on Wednesday, November 6th. The company reported C$0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of C($0.30) by C$0.35. Aurora Cannabis had a negative net margin of 11.53% and a negative return on equity of 6.13%. During the same quarter in the previous year, the firm posted ($0.70) EPS. On average, analysts forecast that Aurora Cannabis Inc. will post -0.22 earnings per share for the current year.
Aurora Cannabis Company Profile
(
Get Free Report)
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.
Featured Articles
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for March 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
